Relmada Therapeutics (RLMD) Other Non Operating Income (2014 - 2020)

Relmada Therapeutics (RLMD) has 7 years of Other Non Operating Income data on file, last reported at -$934919.0 in Q1 2020.

• Other Non Operating Income for Q1 2020 came in at -$934919.0, down 125.13% year-over-year; the trailing twelve-month figure through Mar 2020 was -$4.7 million (down 305.07% YoY), and the FY2019 annual result was -$3.8 million, down 432.44% from the prior year.
• Other Non Operating Income grew to -$934919.0 in Q1 2020 per RLMD's latest filing, from -$3.7 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $13.0 million in Q2 2016 and troughed at -$3.8 million in Q4 2018.
• A 5-year average of $530799.9 and a median of -$66395.0 in 2017 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2018 and 2019: Other Non Operating Income plunged 5486.48% in 2018, then soared 1559.55% in 2019.
• A 5-year view of Other Non Operating Income shows it stood at $449041.0 in 2016, then declined by 24.04% to $341106.0 in 2017, then sank by 1206.54% to -$3.8 million in 2018, then grew by 1.45% to -$3.7 million in 2019, then surged by 74.87% to -$934919.0 in 2020.
• Business Quant data shows RLMD's Other Non Operating Income at -$934919.0 in Q1 2020, -$3.7 million in Q2 2019, and $3.7 million in Q1 2019.